← Eichor
Condition: Mpmri Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mpmri

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Base
Phase N/A · 4 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT05523245An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners
NA · 4 location(s) · Mario Negri Institute for Pharmacological Research · NCT06884410Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
NA · 1 location(s) · University Health Network, Toronto · NCT04856059Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06047106Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
NA · 5 location(s) · Adam S. Kibel, MD · NCT06398639Cognitive and Fusion Prostatic Biopsy
NA · 2 location(s) · Menoufia University · NCT07306741Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Phase N/A · 1 location(s) · University Hospital Muenster · NCT06999174Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT0501034368Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Phase 2/Phase 3 · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07209878A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Phase 1/Phase 2 · 2 location(s) · Memorial Sloan Kettering Cancer Center · NCT05130801HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Phase N/A · 1 location(s) · University of California, Los Angeles · NCT03620786INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NA · 1 location(s) · In Gab Jeong, MD · NCT07398690Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05508126Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI
Phase N/A · 1 location(s) · Assiut University · NCT07202845Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy
Phase N/A · 1 location(s) · Anhui Provincial Hospital · NCT06677775Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer
NA · 15 location(s) · Imperial College London · NCT05574647ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate C
Phase N/A · 5 location(s) · University of California, San Diego · NCT06579417Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Underg
NA · 1 location(s) · National Cancer Institute (NCI) · NCT04692675Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR C
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT05043012Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
NA · 1 location(s) · Salzburger Landeskliniken · NCT06579911Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Phase 3 · 2 location(s) · Region Västerbotten · NCT06565247Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy
NA · 1 location(s) · Ankara Etlik City Hospital · NCT07710807Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)
NA · 14 location(s) · University of Turin, Italy · NCT07580196Partial Prostate Salvage High Dose Rate Brachytherapy
NA · 1 location(s) · British Columbia Cancer Agency · NCT03246802Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT05359653Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT06389786Dose Escalation For INtraprostatic LEsions
Phase 2 · 1 location(s) · Ottawa Hospital Research Institute · NCT05851547Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With
Phase N/A · 2 location(s) · Patrick Schjelderup · NCT06210555
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.